PR Newswire
KINGSEY FALLS, QC, March 1, 2018
KINGSEY FALLS, QC, March 1, 2018 /PRNewswire/ - Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period and the fiscal year ended December 31, 2017.
Q4 2017 Highlights
2017 Annual Highlights
1 | OIBD = Operating income before depreciation and amortization. |
2 | For further details, please refer to the "Supplemental Information on non-IFRS Measures" section. |
3 | Pro-forma basis to include 2017 business combinations on a LTM basis. |
Mr. Mario Plourde, President and Chief Executive Officer, commented: "Our fourth quarter results reflect year-over-year improvements in shipments, sales, and operating income on a consolidated basis. This was driven by solid performances from our containerboard division and European subsidiary Reno de Medici, where more favourable pricing and mix outweighed the impact of higher average raw material costs. In the case of containerboard, results also benefited from the consolidation of the Greenpac Mill results beginning in the second quarter of 2017. The specialty products segment delivered results that were below prior year levels due to a lower contribution from recovery and recycling activities. Our tissue division continued to face challenging market conditions in the fourth quarter, which resulted in production downtime to manage inventory. These factors, combined with a less favourable sales price and product mix, higher raw material prices and costs related to the ramp up of the new Oregon converting facility, impacted sales and profitability levels in this segment.
Sequentially, consolidated fourth quarter results reflected a less pronounced seasonal contraction than in prior years. This was primarily driven by results in our containerboard division, which generated increases in sales and operating income compared to the previous quarter, reflecting lower raw material prices and healthy demand. European boxboard operations also performed well, highlighting stronger business conditions, while results in our specialty products division remained relatively stable. Finally, our tissue segment performance was negatively impacted by lower volumes related to both seasonal demand variations and difficult market conditions, and a less favourable sales price and product mix.
We continued to make progress on strategic initiatives in 2017. At the corporate level, our internal business process transformation and ERP system initiatives progressed well, with implementations now largely completed. In the containerboard group, we finalized the sale of the Maspeth, NY, converting facility in January 2018 for US$72 million, increased our ownership position in the Greenpac Mill to 66.1%, began the construction of a new state-of-the-art containerboard converting facility in New Jersey, and strengthened our position in Canada with the acquisition of three converting plants and purchase of an interest in Tencorr Holdings Corporation. The European boxboard segment also acquired the Italian boxboard processing company Pac Service S.p.A, by purchasing the 66.67% of shares that it did not already own. Finally, we continued to deliver on our commitment to lower our debt. To this end, our leverage ratio1 stood at 3.6x as of the end of 2017, down from 3.8x in 2016, and we successfully redeemed US$200 million of our US-denominated debt, which reduces our interest expense and exposure to currency fluctuations."
1 | Pro-forma basis to include 2017 business combinations on a LTM basis. |
Financial Summary
Selected consolidated information | |||||||||||||||||
| | | | | | | | | | | |||||||
(in millions of Canadian dollars, except amounts per common share) (unaudited) | 2017 | | 2016 | | Q4 2017 | | Q3 2017 | | Q4 2016 | | |||||||
| | | | | | ||||||||||||
Sales | 4,321 | | 4,001 | | 1,082 | | 1,103 | | 979 | | |||||||
As Reported | | | | | | ||||||||||||
| Operating income before depreciation and amortization (OIBD)1 | 390 | | 413 | | 104 | | 104 | | 83 | | ||||||
| Operating income | 175 | | 221 | | 45 | | 51 | | 33 | | ||||||
| Net earnings | 507 | | 135 | | 57 | | 33 | | 4 | | ||||||
| | per common share | $ | 5.35 | | $ | 1.42 | | $ | 0.60 | | $ | 0.35 | | $ | 0.04 | |
Adjusted1 | | | | | | ||||||||||||
| Operating income before depreciation and amortization (OIBD) | 393 | | 403 | | 105 | | 106 | | 82 | | ||||||
| Operating income | 178 | | 211 | | 46 | | 53 | | 32 | | ||||||
| Net earnings | 68 | | 114 | | 13 | | 19 | | 15 | | ||||||
| | per common share | $ | 0.72 | | $ | 1.21 | | $ | 0.14 | | $ | 0.20 | | $ | 0.16 | |
| Margin (OIBD) | 9.1 | % | 10.1 | % Werbung Mehr Nachrichten zur Cascades Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News |